|
- Roche Diagnostics
Roche achieves first CLIA ‘Moderate Complexity’ categorization for Ionify® 25-Hydroxy Vitamin D total test For the first time, a mass spectrometry-based test has achieved this designation, opening access to a broader range of clinical laboratories
- About Us - Roche Diagnostics USA
Roche Diagnostics develops and produces medical tests and digital tools that provide information to help healthcare professionals find the right treatment for patients and deliver the best patient care to improve, prolong and save lives
- Support - Roche Diagnostics USA
Our emphasis on extraordinary customer service — delivered by talented, dedicated people — uniquely positions Roche Diagnostics to lead the way in research and development of creative solutions for unmet medical needs
- Diagnostic solutions - Roche
At Roche Diagnostics, we develop diagnostic tests, instruments and digital solutions with the power to transform healthcare for people around the globe
- Roche Diagnostics - Transforming the way diseases can be prevented . . .
Roche Diagnostics is a division of Roche We develop and integrate diagnostic solutions that address today's challenges and anticipate tomorrow's needs
- Services - Roche Diagnostics USA
Roche Healthcare Consulting Find out how our consulting services can deliver on the needs of your healthcare system
- Roche - Diagnostics
Contact Locations Helpful links Pharma solutions Upcoming events Annual Report 2024 Report a potential side effect Roche websites Diagnostics portal Suppliers information Roche around the world Patients and clinical trials platform Share price 307 40 CHF - 1 90 (-0 61%) Today
- Global operations: The heart of Roche Diagnostics
If they are not of the highest quality or delivered on time, it can mean a disease is not diagnosed or a treatment decision cannot be taken This is why the work of Diagnostics Global Operations matters to patients around the world
|
|
|